1V-LSD Art Blotters – 225mcg

Introduction

1V‑LSD Art Blotters – 225mcg are a 1V‑LSD research chemical delivered on intricately printed blotter‑paper squares, with each unit labeled at 225mcg to support consistent, clearly defined dosing in analytical and research‑oriented settings. The art‑blotter format combines functional, low‑mass loading with a distinctive visual design that can aid in identification and documentation within a laboratory environment, while still strictly adhering to research‑grade handling protocols. This product is supplied exclusively for non‑clinical, laboratory‑based work and is not intended for any application involving human or animal ingestion, treatment, or diagnostic use.

Scientific Overview

1V‑LSD (1‑valeroyl‑lysergic acid diethylamide; commonly known in research contexts by the code name “Valerie”) is a semisynthetic lysergamide closely related to LSD, in which the lysergamide core is modified by a valeroyl (pentanoyl) acyl group on the indole‑nitrogen, creating a distinct N1‑acylated lysergamide structure. Within the research‑chemical literature, lysergamides of this class are typically characterized for their physicochemical behavior, chromatographic profile, and receptor‑binding characteristics without reference to subjective human‑experience data, and they are handled solely as laboratory‑grade reference materials. 1V‑LSD Art Blotters – 225mcg are supplied strictly as a laboratory‑grade lysergamide and must not be used for diagnostic, therapeutic, or consumer‑oriented purposes.

Product Specifications

• Product Name: 1V‑LSD Art Blotters – 225mcg.
• Chemical Name: 1‑Valeroyl‑lysergic acid diethylamide (often supplied as the hemi‑L‑tartrate salt).
• CAS Number: 3028950‑70‑8 (where applicable, depending on supplier practice).
• Compound Class: Novel lysergamide research chemical.
• Form: Decorative blotter‑paper squares with printed artwork and grid‑style markings.
• Dosage per Unit: 225mcg per blotter.
• Purity: Typically ≥ 98–99% research‑grade where confirmed by analytical methods such as HPLC, GC‑MS, NMR, or LC‑MS, with trace impurities kept below established laboratory thresholds.
• Molecular Weight: Approximately 423–425 g/mol in common tartrate‑salt forms.
• Appearance: Compact, artistically designed blotter squares featuring consistent artwork and clear unit separation.
• Quantity: Available in labeled packs (e.g., 5, 10, 25, 50, 100 art blotters), enabling extended experimental runs while maintaining visual distinction and controlled dosing.
• Solubility: Generally soluble in common organic solvents such as ethanol, DMSO, methanol, and acetonitrile, supporting controlled extraction into solution for chromatographic or receptor‑binding studies.
• Storage Conditions: Store in a cool, dry, light‑resistant, low‑humidity environment, tightly sealed in moisture‑resistant, opaque, and light‑blocking packaging; refrigeration at 2–8°C is recommended to help preserve the lysergamide on the blotter substrate and minimize degradation over time.

Laboratory Use Context

1V‑LSD Art Blotters – 225mcg are intended exclusively for in‑vitro, analytical, and non‑clinical research, including lysergamide stability and decomposition testing on printed blotter paper, controlled extraction experiments, chromatographic method development, and forensic or reference‑material work involving N1‑acyl lysergamides. The art‑blotter format supports reproducible mass loading, clear visual identification between units, and straightforward documentation of sample preparation steps, making it especially useful for laboratories focused on quantitative profiling, receptor‑binding studies, or method‑validation projects under controlled, research‑oriented frameworks. This product must not be used in any human or animal‑focused therapeutic, preventive, or diagnostic context and is reserved solely for lawful, laboratory‑based experimentation conducted by qualified personnel.

Quality & Testing

To support rigorous, reproducible science, each batch of 1V‑LSD Art Blotters – 225mcg is accompanied by COA‑based documentation, including batch number, purity estimates, retention‑time data, and a summary of the analytical methods used for characterization where available. Multi‑method verification such as chromatographic profiling, spectrometric analysis, and additional physicochemical tests helps define the material’s profile and reinforces traceability, supporting E‑E‑A‑T‑aligned sourcing for research institutions and analytical laboratories. Clear labeling and batch‑specific records are designed to give laboratories confidence that each art‑designed blotter unit is consistent, well‑defined, and suitable for tightly controlled experimental work involving lysergamide reference standards.

Shipping & Handling

Orders are discreetly packaged in neutral, light‑resistant, and moisture‑resistant, often foil‑or‑pouch‑sealed materials to help maintain the integrity of both the decorative artwork and the lysergamide‑laden blotter paper during transit. Discreet worldwide shipping is offered where permitted by local regulations, with batch‑aware handling and tracking features that support secure delivery and logistical transparency. Packaging is designed to minimize exposure to heat, humidity, and physical shocks, further supporting the stability of the material and ensuring that each art‑blotter square remains intact, visually distinct, and chemically sound upon arrival at the laboratory.

Compliance Disclaimer

For Research Use Only. Not for human consumption.
This product is not intended to diagnose, treat, cure, or prevent any disease and must not be used in any human or animal therapeutic context. 1V‑LSD Art Blotters – 225mcg are strictly reserved for lawful laboratory or analytical research conducted by qualified personnel in accordance with applicable local, national, and international regulations. The legal status of 1V‑LSD and related lysergamides varies significantly by jurisdiction, and it is the responsibility of the purchaser to verify compliance with all relevant laws before ordering, receiving, storing, or handling this material.